To validate the immunogenomic analyses, multiplex IHC with additional T-cell markers revealed that SYNGR3 expression colocalizes with CD4+ T cells but not with CD8+ cytotoxic T cells within the tumor stroma (Supplementary Fig. S3D in Supplementary Materials and Methods S1). This evidence concerns the gene SYNGR3 and neoplasm.